20433T

11/12

髄芽腫6Group of SIOP-Europe. Neuropsychological Outcome of Children Treated for Standard Risk Medul-loblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Stan-dard Radiation Therapy and Maintenance Chemotherapy. Int J Radiat Oncol Biol Phys. 2015；92（5）：978—85.［PMID：26194675］ 8） 8Kamran SC, Goldberg SI, Kuhlthau KA, et al. Quality of life in patients with proton-treated pediatric medulloblastoma：Results of a prospective assessment with 5-year follow-up. Cancer. 2018；124（16）：3390—400.［PMID：29905942］ 9） King AA, Seidel K, Di C, et al. Long-term neurologic health and psychosocial function of adult survi-vors of childhood medulloblastoma／PNET：a report from the Childhood Cancer Survivor Study. Neuro Oncol. 2017；19（5）：689—98.［PMID：28039368］ 10） Salloum R, Chen Y, Yasui Y, et al. Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades：A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2019；37（9）：731—40.［PMID：30730781］ 11） Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemo-therapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol. 2008；26（7）：1112—8.［PMID：18309946 12） Balachandar S, Dunkel IJ, Khakoo Y, et al. Ovarian function in survivors of childhood medulloblas-toma：Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue. Pediatr Blood Cancer. 2015；62（2）：317—21.［PMID：25346052］ 13） Lew SM, Morgan JN, Psaty E, et al. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg. 2006；104（2 Suppl）：103—7.［PMID：16506497］ 14） Packer RJ, Zhou T, Holmes E, et al. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy：results of Children’s Oncology Group trial A9961. Neuro Oncol. 2013；15（1）：97—103.［PMID：23099653］CQ 10　251